Mcdaniel Terry & Co. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,165 shares of the medical equipment provider’s stock after purchasing an additional 459 shares during the quarter. Intuitive Surgical makes up approximately 2.9% of Mcdaniel Terry & Co.’s investment portfolio, making the stock its 13th largest holding. Mcdaniel Terry & Co.’s holdings in Intuitive Surgical were worth $34,470,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter worth about $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the period. LGT Financial Advisors LLC grew its position in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the period. Finally, Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Price Performance
NASDAQ ISRG opened at $511.63 on Friday. The stock has a market capitalization of $181.48 billion, a P/E ratio of 92.35, a PEG ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $523.34. The firm’s 50-day moving average is $486.71 and its two-hundred day moving average is $440.96.
Insiders Place Their Bets
Wall Street Analyst Weigh In
ISRG has been the topic of a number of analyst reports. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Truist Financial lifted their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.
Get Our Latest Analysis on Intuitive Surgical
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What is Short Interest? How to Use It
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.